![Marie-Paul Lachaud](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Marie-Paul Lachaud
Plus aucun poste en cours
Historique de carrière de Marie-Paul Lachaud
Anciens postes connus de Marie-Paul Lachaud
Sociétés | Poste | Début | Fin |
---|---|---|---|
ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 26/03/2013 | - |
Formation de Marie-Paul Lachaud
École Nationale Vétérinaire d'Alfort | Undergraduate Degree |
Université Paris 1 Panthéon-Sorbonne | Doctorate Degree |
Statistiques
Internationale
France | 3 |
Etats-Unis | 2 |
Opérationnelle
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Aratana Therapeutics, Inc.
![]() Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
- Bourse
- Insiders
- Marie-Paul Lachaud
- Expérience